Articleresearch

Intermittent Fasting Produces Similar Weight Loss to Daily Calorie Restriction: What the Research Shows

A 2018 meta-analysis of 11 RCTs (601 participants, 8–24 weeks) found intermittent fasting produces equivalent weight loss to continuous calorie restriction, with a key insulin advantage.

FastingInPractice Editors

Intermittent Fasting Produces Similar Weight Loss to Daily Calorie Restriction: What the Research Shows

Medical disclaimer: This article summarises published research for informational purposes only. It is not medical advice and is not a substitute for guidance from a qualified health professional. Always consult your doctor before starting any fasting protocol, especially if you have an existing health condition or take medication.

Study at a Glance

TitleIntermittent versus continuous energy restriction on weight loss and cardiometabolic outcomes: a systematic review and meta-analysis of randomized controlled trials
JournalJournal of Translational Medicine
PublishedDecember 2018
Study typeSystematic review and meta-analysis of randomized controlled trials
Total participants601 (across 11 included RCTs)
Duration8–24 weeks per included study
Lead researcherIolanda Cioffi
InstitutionUniversity of Naples Federico II, Italy; University of Turin, Italy
FundingNot reported
SourceView on PubMed →

What This Study Looked At

The central question: does intermittent energy restriction (IER) — any form of fasting involving restricted calories on designated days — produce better weight loss and cardiometabolic outcomes than continuous energy restriction (CCR), the traditional "eat less every day" approach?

Cioffi and colleagues systematically searched MEDLINE, EMBASE, Cochrane Library, and other databases through May 2018, identifying all randomized controlled trials that directly compared IER protocols against CCR in overweight or obese adults. Eligible studies needed at least 8 weeks of intervention. The analysis covered weight loss, body composition, blood pressure, blood lipids, and glucose metabolism outcomes. For context on how intermittent fasting affects metabolism overall, fasting and calorie restriction drive weight loss through overlapping but distinct mechanisms.


Who Was Studied

GroupParticipantsWhat They Did
Intermittent energy restriction~300 across 11 trialsFasted on designated days (≤25% of usual daily calories); ate normally on other days — typically 5:2 or alternate-day protocols
Continuous energy restriction~301 across 11 trialsReduced daily caloric intake by a consistent deficit (typically 500–750 kcal/day below maintenance) every day

Participant profile: Adults with overweight or obesity (BMI typically 25–40 kg/m²), age range roughly 20–60 years across studies, mixed male and female populations. Most studies enrolled metabolically healthy participants without active disease. Study durations ranged from 8 to 24 weeks.

How intermittent energy restriction worked in these studies: On designated fasting days, participants consumed no more than 25% of their usual energy intake — typically 400–600 kcal. On non-fasting days, participants were generally given no specific calorie targets, eating normally. The most common protocol tested was the 5:2 pattern: two fasting days per week.


What the Researchers Found

Weight Loss

OutcomeIER vs CCR (WMD)95% CIp-value
Body weight change−0.61 kg in favour of IER−1.70 to 0.470.87 (not significant)
Percent weight loss−0.38% in favour of IER−1.16 to 0.40Not significant
Fat massNo significant differenceNS
Lean massNo significant differenceNS
Waist circumferenceNo significant differenceNS

Both approaches produced meaningful weight loss. The difference between them was not statistically significant. This is a crucial finding: intermittent fasting works — it is simply not reliably superior to daily caloric restriction when total energy intake is matched.

Cardiometabolic Outcomes

OutcomeResult
Fasting insulinIER significantly better: WMD −1.32 μU/mL (95% CI: −2.60 to −0.04, p = 0.04)
HOMA-IR (insulin resistance)Trend towards IER benefit; did not reach significance
Fasting glucoseNo significant difference between groups
Systolic blood pressureNo significant difference
Diastolic blood pressureNo significant difference
LDL cholesterolNo significant difference
HDL cholesterolNo significant difference
Total cholesterolNo significant difference
TriglyceridesNo significant difference

What Did Not Change

  • Lean muscle mass was preserved in BOTH groups — neither IER nor CCR caused meaningful muscle loss at the durations studied
  • Blood pressure, blood lipids, and fasting glucose showed no statistically significant difference between approaches
  • Adherence was broadly similar between groups, though some individual studies reported slightly higher adherence in IER protocols (likely due to the flexibility of non-fasting days)

What the Researchers Concluded

IER produces weight loss and improvements in cardiometabolic markers comparable to CCR in overweight and obese adults. The only statistically significant advantage of the intermittent approach was in fasting insulin, where IER produced a measurably greater reduction than CCR — suggesting the cycling of feast and fast days may have a specific benefit for insulin sensitivity beyond what calorie cutting alone achieves.


What This Means If You Fast

  • Fasting works for weight loss — this meta-analysis confirms it. Across 11 randomized trials and 601 participants, intermittent energy restriction consistently produced meaningful weight loss. Whether you choose 5:2, alternate-day fasting, or another IER protocol, the weight loss evidence is solid.

  • IF is not dramatically "better" than dieting for weight loss. When total calories are similar, both approaches reach similar endpoints on the scale. The advantage of IF is not that it breaks the laws of energy balance — it's that many people find it easier to adhere to, and it produces specific hormonal benefits that daily restriction doesn't always match.

  • The insulin advantage is meaningful. The one outcome where IER clearly outperformed CCR was fasting insulin. This matters because chronically elevated insulin is linked to fat storage, metabolic syndrome, and type 2 diabetes risk. Reducing insulin beyond what weight loss alone achieves is a key biological benefit of the fasting cycle itself. For more on this mechanism, see can intermittent fasting improve insulin sensitivity.

  • Lean mass is safe. Across all 11 trials, neither intermittent nor continuous restriction caused significant muscle loss. This directly refutes the concern that fasting "burns muscle." When studied over 8–24 weeks, lean mass is well-preserved with both approaches.

  • Flexibility matters for adherence. Many people find the feast-day flexibility of a 5:2 pattern easier than the continuous restriction of traditional dieting. If adherence to daily restriction has failed you before, IER offers a psychologically different model — full permission to eat normally on most days — which can improve long-term success. Read more in how intermittent fasting compares to calorie counting.

  • The 5:2 and ADF protocols have the most evidence. Most of the 11 trials in this meta-analysis used 5:2 or alternate-day fasting. Time-restricted daily eating (16:8) had less representation in this 2018 data pool — though subsequent research has built the evidence base for TRE considerably.


Study Limitations

  • Small individual trial sizes: Most of the 11 included RCTs had fewer than 100 participants, which limits statistical power to detect meaningful differences between groups.
  • Short durations: The longest included study ran 24 weeks. Long-term outcomes beyond 6 months are not captured here.
  • Heterogeneity in IF protocols: Studies used different fasting protocols (5:2, alternate-day, modified ADF), making direct comparisons imprecise.
  • Self-reported dietary intake: Most trials relied on participants accurately reporting what they ate on both fasting and non-fasting days — a well-known limitation in nutrition research.
  • Gender distribution: Most trials did not stratify outcomes by sex, limiting conclusions about differential effects in women vs. men.
  • No long-term maintenance data: Weight regain after the study period is not assessed.
  • Industry funding: Not reported across most included studies; potential bias cannot be excluded.

Source

Cioffi I, Evangelista A, Ponzo V, Ciccone G, Soldati L, Santarpia L, Contaldo F, Pasanisi F, Ghigo E, Bo S. Intermittent versus continuous energy restriction on weight loss and cardiometabolic outcomes: a systematic review and meta-analysis of randomized controlled trials. J Transl Med. 2018;16(1):371. doi:10.1186/s12967-018-1748-4. PMID: 30583725


Frequently Asked Questions

Does intermittent fasting produce more weight loss than regular calorie restriction?

Not reliably. This meta-analysis found no statistically significant difference in weight loss between intermittent energy restriction and continuous calorie restriction across 11 RCTs. Both approaches work. The key difference is that many people find fasting protocols easier to follow, and fasting produces specific hormonal benefits — particularly in insulin reduction — that may matter beyond what the scale shows.

Is the 5:2 diet effective for weight loss?

Yes. The 5:2 protocol (two reduced-calorie days per week, five normal eating days) is the most studied form of intermittent energy restriction and consistently produces meaningful weight loss in randomized trials. It is as effective as continuous daily restriction when measured over 8–24 weeks.

Does intermittent fasting preserve muscle better than dieting?

Both intermittent fasting and continuous calorie restriction preserved lean mass in these 11 trials. Neither approach caused significant muscle loss over 8–24 weeks, countering the concern that fasting is particularly harmful to muscle. Adequate protein intake during the eating window is the key protective factor in both cases.

What is HOMA-IR and why does it matter for fasting?

HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) measures how well your body responds to insulin. A lower HOMA-IR means better insulin sensitivity. This meta-analysis found a trend toward IER improving HOMA-IR more than CCR, though the result didn't reach statistical significance. The fasting insulin finding (which was significant) suggests the cycling pattern of IER may specifically benefit insulin pathways beyond the effects of weight loss alone.

Can I eat whatever I want on non-fasting days with a 5:2 protocol?

In most studies included in this meta-analysis, participants were given no specific calorie restrictions on non-fasting days. Despite this, both groups lost similar amounts of weight — suggesting that the restrictive fasting days don't need to be precisely offset by controlled eating days for the protocol to work. That said, food quality matters for overall health and long-term results. Read more in what to eat during intermittent fasting.


Related Research and Articles


Want the complete guide to fasting? Get Intermittent Fasting in Practice on Amazon — and claim 3 months free on our fasting app at fastinginpractice.com/redeem.

📗

Want the complete guide?

Intermittent Fasting in Practice

Everything in this article — and hundreds more pages of practical guidance, protocols, recipes, and mindset strategies — is covered in depth in the book, available now on Amazon.

💬

Have personal experience with this? Your story helps thousands of people.